Patient-reported quality of life after stereotactic body radiotherapy (SBRT), intensity modulated radiotherapy (IMRT), and brachytherapy

Radiotherapy and Oncology

Volumn 116, Issue 2, 2015, Pages 179-184

  Evans, Joseph R ^a   Zhao, Shuang ^a   Daignault, Stephanie ^a   Sanda, Martin G ^b   Michalski, Jeff ^c   Sandler, Howard M ^d   Kuban, Deborah A ^e   Ciezki, Jay ^f   Kaplan, Irving D ^g   Zietman, Anthony L ^h   Hembroff, Larry ⁱ   Feng, Felix Y ^a   Suy, Simeng ^j   Skolarus, Ted A ^a,k   McLaughlin, Patrick W ^a   Wei, John T ^a   Dunn, Rodney L ^a   Finkelstein, Steven E ^l   Mantz, Constantine A ^l   Collins, Sean P ^j   Hamstra, Daniel A ^a   more..

^a UNIVERSITY OF MICHIGAN   (United States)

^b EMORY UNIVERSITY   (United States)

^c UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^d CEDARS SINAI MEDICAL CENTER   (United States)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^f LERNER RESEARCH INSTITUTE   (United States)

^g BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^h MASSACHUSETTS GENERAL HOSPITAL   (United States)

ⁱ MICHIGAN STATE UNIVERSITY   (United States)

^j GEORGETOWN UNIVERSITY   (United States)

^k VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^l 21ST CENTURY ONCOLOGY   (United States)

more..

Author keywords

Brachytherapy; IMRT; Prostate cancer; Quality of life; Stereotactic body radiotherapy (SBRT)

Indexed keywords

ARTICLE; BRACHYTHERAPY; COHORT ANALYSIS; ENTEROPATHY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; SCORING SYSTEM; SEXUAL DYSFUNCTION; STEREOTACTIC BODY RADIATION THERAPY; URINARY TRACT OBSTRUCTION; URINE INCONTINENCE; ADVERSE EFFECTS; AGED; CLINICAL TRIAL; INTESTINAL DISEASES; MIDDLE AGED; MULTICENTER STUDY; PROSTATIC NEOPLASMS; PSYCHOLOGY; RADIOSURGERY; SELF REPORT; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; URINARY INCONTINENCE;

AGED; BRACHYTHERAPY; COHORT STUDIES; HUMANS; INTESTINAL DISEASES; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; QUALITY OF LIFE; RADIOSURGERY; RADIOTHERAPY, INTENSITY-MODULATED; SELF REPORT; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; URINARY INCONTINENCE;

EID: 84953840072     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2015.07.016     Document Type: Article

References (34)

1. M.G. Sanda, R.L. Dunn, J. Michalski, H.M. Sandler, L. Northouse, L. Hembroff, and et al. Quality of life and satisfaction with outcome among prostate-cancer survivors N Eng J Med 358 2008 1250 1261
2. R.C. Chen, J.A. Clark, and J.A. Talcott Individualizing quality-of-life outcomes reporting: how localized prostate cancer treatments affect patients with different levels of baseline urinary, bowel, and sexual function J Clin Oncol 27 2009 3916 3922
3. M. Ferrer, J.F. Suarez, F. Guedea, P. Fernandez, V. Macias, A. Marino, and et al. Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer Int J Radiat Oncol Biol Phys 72 2008 421 432
4. M. Ferrer, F. Guedea, J.F. Suarez, B. de Paula, V. Macias, A. Marino, and et al. Quality of life impact of treatments for localized prostate cancer: cohort study with a 5 year follow-up Radiother Oncol 108 2013 306 313
5. I.R. Vogelius, and S.M. Bentzen Meta-analysis of the alpha/beta ratio for prostate cancer in the presence of an overall time factor: bad news, good news, or no news? Int J Radiat Oncol Biol Phys 85 2013 89 94
6. L.N. Chen, S. Suy, S. Uhm, E.K. Oermann, A.W. Ju, V. Chen, and et al. Stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience Radiat Oncol. 8 2013 58
7. J.C. Hodges, Y. Lotan, T.P. Boike, R. Benton, A. Barrier, and R.D. Timmerman Cost-effectiveness analysis of stereotactic body radiation therapy versus intensity-modulated radiation therapy: an emerging initial radiation treatment option for organ-confined prostate cancer J Oncol Pract 8 2012 e31s 37s
8. N.P. Amin, D.J. Sher, and A.A. Konski Systematic review of the cost effectiveness of radiation therapy for prostate cancer from 2003 to 2013 Appl Health Econ Health Policy 12 2014 391 408
9. J.B. Yu, L.D. Cramer, J. Herrin, P.R. Soulos, A.L. Potosky, and C.P. Gross Stereotactic body radiation therapy versus intensity-modulated radiation therapy for prostate cancer: comparison of toxicity J Clin Oncol 2014
10. A.V. D'Amico Stereotactic body radiation therapy versus intensity-modulated radiation therapy for prostate cancer: less cost at the expense of more genitourinary toxicity is a concerning but testable hypothesis J Clin Oncol 2014
11. D.W. Kim, L.C. Cho, C. Straka, A. Christie, Y. Lotan, D. Pistenmaa, and et al. Predictors of rectal tolerance observed in a dose-escalated phase 1-2 trial of stereotactic body radiation therapy for prostate cancer Int J Radiat Oncol Biol Phys 89 2014 509 517
12. C.R. King, S. Collins, D. Fuller, P.C. Wang, P. Kupelian, M. Steinberg, and et al. Health-related quality of life after stereotactic body radiation therapy for localized prostate cancer: results from a multi-institutional consortium of prospective trials Int J Radiat Oncol Biol Phys 87 2013 939 945
13. O. Bhattasali, L.N. Chen, J. Woo, J.W. Park, J.S. Kim, R. Moures, and et al. Patient-reported outcomes following stereotactic body radiation therapy for clinically localized prostate cancer Radiati oncol 9 2014 52
14. A.J. Katz, M. Santoro, F. Diblasio, and R. Ashley Stereotactic body radiotherapy for localized prostate cancer: disease control and quality of life at 6 years Radiat Oncol 8 2013 118
15. E.A. Wiegner, and C.R. King Sexual function after stereotactic body radiotherapy for prostate cancer: results of a prospective clinical trial Int J Radiat Oncol Biol Phys 78 2010 442 448
16. D.A. Hamstra, A.S. Conlon, S. Daignault, R.L. Dunn, H.M. Sandler, A.L. Hembroff, and et al. Multi-institutional prospective evaluation of bowel quality of life after prostate external beam radiation therapy identifies patient and treatment factors associated with patient-reported outcomes: the PROSTQA experience Int J Radiat Oncol Biol Phys 86 2013 546 553
17. C.A.F. Mantz, I. Zucker, and S. Harrison A phase II trial of real-time target tracking sbrt for low-risk prostate cancer utilizing the calypso 4D localization system: patient-reported quality of life and toxicity outcomes Int J Radiat Oncol Biol Phys 81 2011 S100
18. J.T. Wei, R.L. Dunn, M.S. Litwin, H.M. Sandler, and M.G. Sanda Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer Urology 56 2000 899 905
19. J. Ware Jr., M. Kosinski, and S.D. Keller A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity Med Care 34 1996 220 233
20. T.A. Skolarus, R.L. Dunn, M.G. Sanda, P. Chang, T.K. Greenfield, M.S. Litwin, and et al. Minimally important difference for the expanded prostate cancer index composite short form Urology 85 2015 101 106
21. J.M. Crook, A. Gomez-Iturriaga, K. Wallace, C. Ma, S. Fung, S. Alibhai, and et al. Comparison of health-related quality of life 5 years after SPIRIT: surgical prostatectomy versus interstitial radiation intervention trial J Clin Oncol 29 2011 362 368
22. M.J. Barry, F.J. Fowler Jr., M.P. O'Leary, R.C. Bruskewitz, H.L. Holtgrewe, W.K. Mebust, and et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association J Urol 148 1992 1549 1557
23. A.L. Potosky, L.C. Harlan, J.L. Stanford, F.D. Gilliland, A.S. Hamilton, P.C. Albertsen, and et al. Prostate cancer practice patterns and quality of life: the Prostate Cancer Outcomes Study J Natl Cancer Inst 91 1999 1719 1724
24. A.L. Potosky, W.W. Davis, R.M. Hoffman, J.L. Stanford, R.A. Stephenson, D.F. Penson, and et al. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study J Natl Cancer Inst 96 2004 1358 1367
25. J.A. Talcott, J. Manola, R.C. Chen, J.A. Clark, I. Kaplan, A.V. D'Amico, and et al. Using patient-reported outcomes to assess and improve prostate cancer brachytherapy BJU Int 2013
26. H.M. Sandler, P.Y. Liu, R.L. Dunn, D.C. Khan, S.E. Tropper, M.G. Sanda, and et al. Reduction in patient-reported acute morbidity in prostate cancer patients treated with 81-Gy Intensity-modulated radiotherapy using reduced planning target volume margins and electromagnetic tracking: assessing the impact of margin reduction study Urology 75 2010 1004 1008
27. J. Vainshtein, E. Abu-Isa, K.B. Olson, M.E. Ray, H.M. Sandler, D. Normolle, and et al. Randomized phase II trial of urethral sparing intensity modulated radiation therapy in low-risk prostate cancer: implications for focal therapy Radiat Oncol 7 2012 82
28. D.C. Miller, M.G. Sanda, R.L. Dunn, J.E. Montie, H. Pimentel, H.M. Sandler, and et al. Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy J Clin Oncol 23 2005 2772 2780
29. S.L. Liauw, R.R. Weichselbaum, C. Rash, D. Correa, H.A. Al-Hallaq, C.A. Pelizzari, and et al. Biochemical control and toxicity after intensity-modulated radiation therapy for prostate cancer Technol Cancer Res Treat 8 2009 201 206
30. L.C. Cho, R. Timmerman, and B. Kavanagh Hypofractionated external-beam radiotherapy for prostate cancer Prostate Cancer 2013 2013 103547
31. J. Phan, D.A. Swanson, L.B. Levy, R.J. Kudchadker, T.L. Bruno, and S.J. Frank Late rectal complications after prostate brachytherapy for localized prostate cancer: incidence and management Cancer 115 2009 1827 1839
32. Phase III study of HYPOfractionated RadioTherapy of intermediate risk localised Prostate Cancer, < http://www.controlled-trials.com/ISRCTN45905321 > (accessed 7/22/14).
33. Radiation Hypofractionation Via Extended Versus Accelerated Therapy (HEAT) For Prostate Cancer, < http://www.clinicaltrials.gov/show/NCT01794403 > (accessed 7/22/14).
34. International randomised study of laparoscopic prostatectomy vs stereotactic body radiotherapy (SBRT) and conventionally fractionated radiotherapy vs SBRT for early stage organ-confined prostate cancer, < http://www.isrctn.com/ISRCTN17627211 > (accessed 5/6/2015).